Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge Xestospongia sp., in Mediating Non-Small-Cell Lung Cancer Cell Apoptosis. | Molecules | 2022 | 36558080 | PubTator, text mining | PubMed |
| The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells. | Int J Mol Sci | 2022 | 36555795 | PubTator, text mining | PubMed |
| The Emerging Burden of Genetic Instability and Mutation in Melanoma: Role of Molecular Mechanisms. | Cancers (Basel) | 2022 | 36551688 | PubTator, text mining | PubMed |
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Potential Diets to Improve Mitochondrial Activity in Amyotrophic Lateral Sclerosis. | Diseases | 2022 | 36547203 | PubTator, text mining | PubMed |
| Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics. | Front Pharmacol | 2022 | 36545311 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors. | Stem Cell Res Ther | 2022 | 36536420 | PubTator, text mining | PubMed |
| N1-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents. | Molecules | 2022 | 36500543 | PubTator, text mining | PubMed |
| The PI3K/Akt Pathway in Meta-Inflammation. | Int J Mol Sci | 2022 | 36499659 | PubTator, text mining | PubMed |
| IL-1RAP, a Key Therapeutic Target in Cancer. | Int J Mol Sci | 2022 | 36499246 | PubTator, text mining | PubMed |
| Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. | Int J Mol Sci | 2022 | 36498861 | PubTator, text mining | PubMed |
| New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways. | Cancers (Basel) | 2022 | 36497321 | PubTator, text mining | PubMed |
| Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery. | Cancers (Basel) | 2022 | 36497286 | PubTator, text mining | PubMed |
| Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD. | PLoS One | 2022 | 36480517 | PubTator, text mining | PubMed |
| Potential role of microRNAs in selective hepatic insulin resistance: From paradox to the paradigm. | Front Endocrinol (Lausanne) | 2022 | 36479211 | PubTator, text mining | PubMed |
| Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives. | Cancer Biol Med | 2022 | 36476337 | PubTator, text mining | PubMed |
| Advancement of secretory breast carcinoma: a narrative review. | Ann Transl Med | 2022 | 36467350 | PubTator, text mining | PubMed |
| Specific decellularized extracellular matrix promotes the plasticity of human ocular surface epithelial cells. | Front Med (Lausanne) | 2022 | 36457571 | PubTator, text mining | PubMed |
| Secretory autophagy promotes Rab37-mediated exocytosis of tissue inhibitor of metalloproteinase 1. | J Biomed Sci | 2022 | 36457117 | PubTator, text mining | PubMed |
| Role of RAS signaling in ovarian cancer. | F1000Res | 2022 | 36451660 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=18